UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.22 +0.84 (+1.07%) GOLD FUTURES
2,316.10 -8.10 (-0.35%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,239.89 -1,274.61 (-2.52%)
Orexo AB (publ) (ORXOY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 10:00AM EDT
| Previous close | 1.6500 |
| Open | 1.6500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.6500 - 1.6500 |
| 52-week range | 0.7600 - 1.7100 |
| Volume | |
| Avg. volume | 73 |
| Market cap | 61.147M |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3400 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireReport from Orexo AB's annual general meeting, 26 April 2024
Election of the board of directors and auditor
PR NewswireOrexo extends patent protection for its nasal epinephrine powder product OX640 in the US
Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that the United States Patent and Trademark Office (USPTO) has granted another US patent specifically related to OX640, Orexo's nasal epinephrine powder product based on the AmorphOX® drug delivery platform.
© 2024 Yahoo. All rights reserved.